To determine relevant demographics, clinical features, and outcomes for septic arthritis in patients on haemodialysis for end-stage renal failure. Methods. A multi-centre retrospective review was performed from 1999 to 2005. Results. 15 cases were identified. The mean age of the patients at diagnosis was 67 (range, 23-89) years and 11 were male. All had multiple co-morbidities and additional risk factors for sepsis. The primary sources of sepsis were dialysis access-related (n=12), unknown in 2, and unrelated soft tissue infection in one. All patients presented with acute monoarticular symptoms; the knee joint was affected in 11 patients. The white cell count, neutrophil count, and C-reactive protein concentration were elevated in 10, 10, and 15 patients, respectively. All patients had positive synovial fluid cultures and blood Septic arthritis in haemodialysis patients: a seven-year multi-centre review
cultures were positive in 14. Organisms isolated were all skin commensals, being staphylococcal in 13 and streptococcal in 2. Six patients had concomitant rheumatological disease (gout in 4, pseudogout in one, and rheumatoid arthritis in one). Two had urate crystals in the synovial fluid (noted by microscopy). All patients underwent antimicrobial therapy for a mean of 36 days, together with joint washouts and debridement. 12 patients were cured of infection; 2 developed chronic sepsis secondary to localised osteomyelitis; and one died of sepsis. Conclusion. Septic arthritis is a potentially devastating condition. Early and aggressive joint lavage and debridement combined with appropriate antimicrobial therapy is imperative. A high index of suspicion is necessary in haemodialysis patients; the diagnosis of septic arthritis must be presumed until proven otherwise.
INTRODUCTION
Septic arthritis is an orthopaedic emergency requiring prompt treatment with joint lavage and debridement in combination with antimicrobial therapy. Patients with end-stage renal failure (ESRF) on haemodialysis (HD) are at increased risk of developing this condition, as they have defective cellular and humoral immunity, 1 require multiple invasive procedures for urinary and vascular access, which promotes bacteraemia. Frequently, they also have other immunosuppressive co-morbidities such as diabetes mellitus and steroid use. 2, 3 In addition, these patients have many possible aseptic causes for arthritis, making early diagnosis difficult. As HD for the treatment of ESRF becomes more common, so will the incidence of septic arthritis.
MATERIALS AND METHODS
We performed a multi-centre retrospective analysis of all adult ESRF patients on HD presenting with septic arthritis to Leeds General Infirmary, St James University Hospital, and York District Hospital from 1999 to 2005. To ensure consistency, all patient notes, imaging, and electronic records were reviewed by a single reviewer.
RESULTS
15 cases of septic arthritis in ESRF patients were identified. The incidence of microbiologically proven septic arthritis in our patient group was under 0.5% per year. Our patients were predominantly elderly (mean age, 67; range, 23-89 years) and male (11/15) . The mean duration of ESRF and HD was 5.5 (range, 3-9) years. The aetiology of the ESRF was hypertensive nephropathy in 5, diabetic nephropathy in 5, unknown in 3, immunoglobulin A nephropathy in one, and systemic lupus erythematosus-associated vasculitis in one. The mode of access for HD consisted of: catheters in 8, arteriovenous (AV) grafts in 4, and AV fistulas in 3.
All patients had multiple co-morbidities for sepsis, including ischaemic heart disease, congestive cardiac failure, diabetes mellitus, rheumatological disease, chronic obstructive pulmonary disease, and steroid use ( Table 1) .
All patients presented with joint pain, constitutional upset, and a painful, decreased range of movement. Pyrexia was present in 12 patients. The joint most commonly affected was the knee (n=11). All cases were mono-articular. The white cell count, neutrophil count, and C-reactive protein level were elevated in 10, 10, and 15 patients, respectively. All the patients had positive synovial fluid cultures and 14 had positive blood cultures ( 
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All the patients underwent antimicrobial therapy with joint washouts and debridement. For the 12 patients cured of infection, intravenous antimicrobials used were: flucloxacillin in 6 and vancomycin, rifampicin or benzylpenicillin in 2 each. Oral antimicrobials used were: flucloxacillin in 6, rifampicin in 4, and phenoxymethyl penicillin (Penicillin V) in 2. 13 patients underwent arthroscopy alone and 2 underwent arthroscopy followed by open surgery; 12 of them had these procedures on the day of the presumptive diagnosis.
12 patients were cured of infection, 2 developed chronic sepsis secondary to localised osteomyelitis, and one died of sepsis. In the 2 patients developing osteomyelitis, one was eventually cured of infection following a 2-stage arthroplasty and the other after a Girdlestone arthroplasty. There were no recurrences of infection at one year (Table 3) .
DISCUSSION
Our patients were predominantly elderly and male, similar to the demographics of other general septic arthritis series. [4] [5] [6] All our patients had concomitant systemic risk factors for sepsis; diabetes mellitus being the most common. Diabetes is also the number one systemic risk factor identified in general septic arthritis and for sepsis in general, possibly due to sustained hyperglycaemia retarding neutrophil chemotaxis. 7 Other common systemic risk factors were: steroid use, malignancy, and alcoholic liver disease, which are also well-documented risk factors for septic arthritis in general, though even higher incidences prevailed in our series. [4] [5] [6] Our incidence of rheumatological disease was much higher than in other series. 6 Such joint conditions can present with the same symptoms, signs, and raised markers of inflammation as in septic arthritis, and dual pathology is not uncommon. 8 It is therefore important to perform diagnostic joint aspirations and assume sepsis is present until proven otherwise by negative cultures, even when synovial microscopy reveals low white cell count, no organisms, and a crystal arthropathy.
All of our patients were infected via haematogenous spread. This was expected as over 70% of all septic arthritis cases are due to haematogenous spread 9 and ESRF patients on HD are particularly at risk of access-related infections and bacteraemia. 10 All the organisms isolated in our series were skin commensals, which was in keeping with the primary sources of infection. Almost all our cases were caused by staphylococci; S aureus accounts for 44% to 67% of all isolates in general septic arthritis series, 4, 11 and HD patients are more likely to have S aureus as the cause of their bacteraemia. This is at least in part due to their high nasal carriage rates of S aureus. 12 Interestingly only 3 of our patients were infected by methicillinresistant S aureus. Due to frequent hospitalisations these patients are at high risk of acquiring drugresistant organisms. 13 Clinical presentation was similar to other case series, including joint pain, systemic upset, a painful, decreased range of movement, and the knee being the most commonly affected joint. 9, 14 It has been suggested that septic arthritis in ESRF patients on HD was similar to intravenous drug abusers, and occurs more commonly in joints above the diaphragm, 15, 16 but our findings did not conform to this pattern. In keeping with other series of patients with general septic arthritis, the white cell and neutrophil counts of our patients were not sensitive indicators of the condition. 17 Our patients had a higher incidence of positive blood cultures than in other series, 14, 17 consistent with all our patients' infections being haematogenous and most were access related.
Treatment consisted of antimicrobial therapy and operative intervention in all cases. The mean length of combined intravenous and oral antimicrobial therapy in the 12 patients cured of infection was about 5 weeks, which is in keeping with the 4 to 6 weeks recommended by other studies. 6, 14, 17 The blood concentrations of antimicrobials vary enormously in patients with ESRF on HD, and antimicrobial type and dosing regimens should only be selected after consultation with microbiology and renal teams. Our series had a higher rate of surgical intervention than did others (100% vs 30%). 6, 14 This probably reflects local practice, where possible septic arthritis cases are referred to the orthopaedic team while elsewhere they may be referred to rheumatology teams, which are more likely to advocate simple joint aspiration over surgical intervention. 18 The mortality rate of our patients (7%) lies at the lower end rates quoted for general septic arthritis (2% to 17%) 4, 19 and the 22% in HD-associated septic arthritis. 15 Although our patients were predominantly elderly with multiple co-morbidities and presumably had little physiological reserve, the outcomes were very favourable, possibly because the patients were managed by multi-disciplinarily renal, orthopaedic, and microbiology teams. Our renal teams have a low threshold for requesting orthopaedic input and performing arthrocentesis, in patients with ESRF on HD who have arthralgia. Our orthopaedic teams have adopted rapid and aggressive approaches to joint lavage and debridement. Moreover, decisions regarding antimicrobial therapy tended to be made in close collaboration with the microbiology unit. As a result, 12 of our patients were presumptively diagnosed as having septic arthritis on the day of symptomatic presentation and underwent surgery on the same day.
CONCLUSION
Septic arthritis is an orthopaedic emergency with high morbidity and mortality. As HD for the treatment of ESRF becomes more common, so will the incidence of septic arthritis. Encouragingly despite their frailty, patient outcomes are good when they are managed with early and aggressive joint lavage and debridement combined with appropriate antimicrobial therapy. To ensure patients are treated early, it is imperative to have a high index of suspicion for septic arthritis and that sepsis is presumed to be the cause of arthralgia until proven otherwise.
